Shoji Kagami
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shoji Kagami has a total of 248 co-authors. Here are the top co-authors by number of shared publications:
Shuji Kondo
5 shared publicationsYasuhiro Kuroda
5 shared publicationsMaki Shimizu
The University of Tokushima Graduate School
3 shared publicationsMaki Urushihara
The University of Tokushima Graduate School
3 shared publicationsMasanori Takamatsu
Department of Pediatrics, The Institute of Health Bioscience, The University of Tokushima Graduate School, Kuramoto-cho-3-chome, Tokushima, Japan
3 shared publicationsKaname Okada
2 shared publications
Latest Publications
- Open Access
- 2 December 2011
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 16 (2) , 214-220
Involvement of glomerular renin−angiotensin system (RAS) activation in the development and progression of glomerular injury
Recently, there has been a paradigm shift away from an emphasis on the role of the endocrine (circulating) renin−angiotensin system (RAS) in the regulation of the sodium and extracellular fluid balance, blood pressure, and the pathophysiology of hypertensive organ damage toward a focus on the role of tissue RAS found in many organs, including kidney. A tissue RAS implies that RAS components necessary for the production of angiotensin II (Ang II) reside within the tissue and its production is regulated within the tissue, independent of the circulating RAS. Locally produced Ang II plays a role in many physiological and pathophysiological processes such as hypertension, inflammation, oxidative stress, and tissue fibrosis. Both glomerular and tubular compartments of the kidney have the characteristics of a tissue RAS. The purpose of this article is to review the recent advances in tissue RAS research with a particular focus on the role of the glomerular RAS in the progression of renal disease.
- 2 December 2011
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 16 (2) , 214-220
Open AccessInvolvement of glomerular renin−angiotensin system (RAS) activation in the development and progression of glomerular injury
Recently, there has been a paradigm shift away from an emphasis on the role of the endocrine (circulating) renin−angiotensin system (RAS) in the regulation of the sodium and extracellular fluid balance, blood pressure, and the pathophysiology of hypertensive organ damage toward a focus on the role of tissue RAS found in many organs, including kidney. A tissue RAS implies that RAS components necessary for the production of angiotensin II (Ang II) reside within the tissue and its production is regulated within the tissue, independent of the circulating RAS. Locally produced Ang II plays a role in many physiological and pathophysiological processes such as hypertension, inflammation, oxidative stress, and tissue fibrosis. Both glomerular and tubular compartments of the kidney have the characteristics of a tissue RAS. The purpose of this article is to review the recent advances in tissue RAS research with a particular focus on the role of the glomerular RAS in the progression of renal disease.
- 1 January 2011
- Vol. 53 (1) , 10-4
[Progress of pediatric nephrology].
- Open Access
- 1 January 2009
- Published by Oxford University Press (OUP) in NDT Plus
- Vol. 2 (Supplement) , ii1115
Renal histopathology
- 1 January 2009
- Published by Oxford University Press (OUP) in NDT Plus
- Vol. 2 (Supplement) , ii1115
Open AccessRenal histopathology
- Open Access
- 18 April 2008
- Published by Springer Nature in Pediatric Nephrology
- Vol. 23 (8) , 1257-1267
Glomerular angiotensinogen protein is enhanced in pediatric IgA nephropathy
Enhanced intrarenal renin-angiotensin system (RAS) is implicated in the development and progression of renal injury. To investigate whether angiotensinogen (AGT) expression is involved in glomerular RAS activity and glomerular injury, we examined glomerular AGT expression and its correlation with expression of other RAS components, and levels of glomerular injury in samples from patients with immunoglobulin A nephropathy (IgAN) (23) and minor glomerular abnormalities (MGA) (8). Immunohistochemistry showed that AGT protein was highly expressed by glomerular endothelial cells (GEC) and mesangial cells in nephritic glomeruli of IgAN compared with glomeruli of MGA. Levels of glomerular AGT protein were well correlated with levels of glomerular angiotensin II (ang II), transforming growth factor-β (TGF-β), α-smooth-muscle actin, glomerular cell number, and glomerulosclerosis score but not with those of glomerular angiotensin-converting enzyme and ang II type 1 receptor. Real-time polymerase chain reaction (RT-PCR) and Western blot analyses using cultured human GEC indicated that ang II upregulated AGT messenger ribonucleic acid (mRNA) and protein expression in a dose- and time-dependent manner. These data suggest that activated glomerular AGT expression is likely involved in elevated local ang II production and, thereby, may contribute to increased TGF-β production and development of glomerular injury in IgAN. Augmentation of GEC-AGT production with ang II stimulation might drive further glomerular injury in a positive-feedback loop.
- 18 April 2008
- Published by Springer Nature in Pediatric Nephrology
- Vol. 23 (8) , 1257-1267
Open AccessGlomerular angiotensinogen protein is enhanced in pediatric IgA nephropathy
Enhanced intrarenal renin-angiotensin system (RAS) is implicated in the development and progression of renal injury. To investigate whether angiotensinogen (AGT) expression is involved in glomerular RAS activity and glomerular injury, we examined glomerular AGT expression and its correlation with expression of other RAS components, and levels of glomerular injury in samples from patients with immunoglobulin A nephropathy (IgAN) (23) and minor glomerular abnormalities (MGA) (8). Immunohistochemistry showed that AGT protein was highly expressed by glomerular endothelial cells (GEC) and mesangial cells in nephritic glomeruli of IgAN compared with glomeruli of MGA. Levels of glomerular AGT protein were well correlated with levels of glomerular angiotensin II (ang II), transforming growth factor-β (TGF-β), α-smooth-muscle actin, glomerular cell number, and glomerulosclerosis score but not with those of glomerular angiotensin-converting enzyme and ang II type 1 receptor. Real-time polymerase chain reaction (RT-PCR) and Western blot analyses using cultured human GEC indicated that ang II upregulated AGT messenger ribonucleic acid (mRNA) and protein expression in a dose- and time-dependent manner. These data suggest that activated glomerular AGT expression is likely involved in elevated local ang II production and, thereby, may contribute to increased TGF-β production and development of glomerular injury in IgAN. Augmentation of GEC-AGT production with ang II stimulation might drive further glomerular injury in a positive-feedback loop.
- Open Access
- 23 May 2006
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 21 (9) , 2380-2390
Role of integrin-linked kinase in epithelial–mesenchymal transition in crescent formation of experimental glomerulonephritis
Background. Glomerular parietal epithelial–mesenchymal transition (EMT) is a key event in crescent formation of glomerulonephritis (GN). Integrin-linked kinase (ILK) is an integrin cytoplasmic-binding protein that has been implicated in the regulation of cell adhesion, extracellular matrix organization and EMT. Transforming growth factor-β (TGF-β) is involved in the induction and progression of EMT in several tissues. Methods. To investigate whether ILK is involved in the crescent formation in GN, we studied the expression of ILK protein and activity in crescentic GN induced in Wistar Kyoto (WKY) rats. In addition, we investigated whether transforming growth factor-β1 (TGF-β1) could induce glomerular EMT and ILK by using cultured parietal epithelial cell (PEC). Results. The expression of ILK was strongly induced in cellular crescents at day 7 and followed by a decrease in fibrocellular crescents at day 28. ILK-expressing cells in cellular crescents were double-positive for protein gene product 9.5 (PEC marker), α-smooth muscle actin (α-SMA, myofibroblasts marker) and TGF-β1, indicating a possible contribution of ILK and TGF-β1 to EMT in crescent formation in GN. Consistent with the finding of histological ILK expression in crescents, western blot and kinase activity assay showed an increase in both ILK protein and activity, peaking at day 7 of GN (3.7- and 3.5-fold of control, respectively). The expression of ILK increased to 3.1-fold of control when EMT was induced in cultured PEC by TGF-β1. Conclusion. The present results provide the first evidence that expression and activity of ILK are increased in cellular crescents of experimental GN. Enhanced expression and activity of ILK, possibly by TGF-β1, is associated with the induction of EMT by PEC and thereby, may participate in the formation of cellular crescents in GN.
- 23 May 2006
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 21 (9) , 2380-2390
Open AccessRole of integrin-linked kinase in epithelial–mesenchymal transition in crescent formation of experimental glomerulonephritis
Background. Glomerular parietal epithelial–mesenchymal transition (EMT) is a key event in crescent formation of glomerulonephritis (GN). Integrin-linked kinase (ILK) is an integrin cytoplasmic-binding protein that has been implicated in the regulation of cell adhesion, extracellular matrix organization and EMT. Transforming growth factor-β (TGF-β) is involved in the induction and progression of EMT in several tissues. Methods. To investigate whether ILK is involved in the crescent formation in GN, we studied the expression of ILK protein and activity in crescentic GN induced in Wistar Kyoto (WKY) rats. In addition, we investigated whether transforming growth factor-β1 (TGF-β1) could induce glomerular EMT and ILK by using cultured parietal epithelial cell (PEC). Results. The expression of ILK was strongly induced in cellular crescents at day 7 and followed by a decrease in fibrocellular crescents at day 28. ILK-expressing cells in cellular crescents were double-positive for protein gene product 9.5 (PEC marker), α-smooth muscle actin (α-SMA, myofibroblasts marker) and TGF-β1, indicating a possible contribution of ILK and TGF-β1 to EMT in crescent formation in GN. Consistent with the finding of histological ILK expression in crescents, western blot and kinase activity assay showed an increase in both ILK protein and activity, peaking at day 7 of GN (3.7- and 3.5-fold of control, respectively). The expression of ILK increased to 3.1-fold of control when EMT was induced in cultured PEC by TGF-β1. Conclusion. The present results provide the first evidence that expression and activity of ILK are increased in cellular crescents of experimental GN. Enhanced expression and activity of ILK, possibly by TGF-β1, is associated with the induction of EMT by PEC and thereby, may participate in the formation of cellular crescents in GN.
- 1 March 2006
- Published by Elsevier in Life Sciences
- Vol. 78 (16) , 1794-1800
Up-regulation of integrin-linked kinase activity in rat mesangioproliferative glomerulonephritis
- 1 March 2006
- Published by Elsevier in Life Sciences
- Vol. 78 (16) , 1794-1800
Up-regulation of integrin-linked kinase activity in rat mesangioproliferative glomerulonephritis
- 13 December 2002
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 299 (4) , 555-561
Endothelin-1 is a potent stimulator of α1β1 integrin-mediated collagen matrix remodeling by rat mesangial cells
- 13 December 2002
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 299 (4) , 555-561
Endothelin-1 is a potent stimulator of α1β1 integrin-mediated collagen matrix remodeling by rat mesangial cells
- Open Access
- 1 January 1998
- Published by Japanese Society for Pediatric Nephrology in Japanese journal of pediatric nephrology
- Vol. 11 (2) , 165-170
Glomerular distribution and gelatinolytic activity of matrix metalloproteinases in human glomerulonephritis.
Background. Matrix metalloproteinases (MMPs) have been implicated in the development of glomerular injury in rat experimental glomerulonephritis (GN). However, the significance of MMPs in human GN remains obscure. In order to evaluate the role of MMPs in human GN, we examined the glomerular distribution and gelatinolytic activities of MMP-2 and MMP-9 in human GN. Methods. We performed immunohistochemistry with polyclonal anti-MMP-2 and MMP-9 antibodies, and analysed gelatin zymograms of five isolated glomeruli from various types of human renal disease. The renal specimens investigated were from normal kidneys (ns5), IgA nephritis (ns20), Henoch-Schonlein neph- ritis (ns4), non-IgA mesangial proliferative GN (ns9), lupus nephritis (ns6), acute poststreptococcal GN (APSGN) (ns4) and diabetic nephropathy (DN) (ns4). Results. MMP-2 immunoreactivity was not detected in normal controls or in any type of GN. MMP-9 staining, which was almost negative in normal glomeruli, was increased mainly in the mesangial region and corresponded to the level of glomerular cell proliferative changes in mesangial proliferative GN (IgA nephritis, Henoch-Schonlein nephritis, non- IgA mesangial proliferative GN and lupus nephritis). Positive but weak staining for MMP-9 was observed in mesangial areas in DN. In addition, double immuno- staining showed that MMP-9 is colocalized in scattered neutrophils within diseased glomeruli in APSGN. MMP-9 gelatinolytic activity in five normal glomeruli was weakly detected. Consistent with the levels of immunostaining, MMP-9 glomerular activity was dra- matically increased in nephritic glomeruli with IgA nephritis, lupus nephritis and DN. The gelatinolytic activity of MMP-2 was occasionally detectable in nephritic glomeruli. Conclusion. These results strongly suggest that MMP-9 plays an important role in abnormal mesangial proliferative changes in human GN.
- 1 January 1998
- Published by Japanese Society for Pediatric Nephrology in Japanese journal of pediatric nephrology
- Vol. 11 (2) , 165-170
Open AccessGlomerular distribution and gelatinolytic activity of matrix metalloproteinases in human glomerulonephritis.
Background. Matrix metalloproteinases (MMPs) have been implicated in the development of glomerular injury in rat experimental glomerulonephritis (GN). However, the significance of MMPs in human GN remains obscure. In order to evaluate the role of MMPs in human GN, we examined the glomerular distribution and gelatinolytic activities of MMP-2 and MMP-9 in human GN. Methods. We performed immunohistochemistry with polyclonal anti-MMP-2 and MMP-9 antibodies, and analysed gelatin zymograms of five isolated glomeruli from various types of human renal disease. The renal specimens investigated were from normal kidneys (ns5), IgA nephritis (ns20), Henoch-Schonlein neph- ritis (ns4), non-IgA mesangial proliferative GN (ns9), lupus nephritis (ns6), acute poststreptococcal GN (APSGN) (ns4) and diabetic nephropathy (DN) (ns4). Results. MMP-2 immunoreactivity was not detected in normal controls or in any type of GN. MMP-9 staining, which was almost negative in normal glomeruli, was increased mainly in the mesangial region and corresponded to the level of glomerular cell proliferative changes in mesangial proliferative GN (IgA nephritis, Henoch-Schonlein nephritis, non- IgA mesangial proliferative GN and lupus nephritis). Positive but weak staining for MMP-9 was observed in mesangial areas in DN. In addition, double immuno- staining showed that MMP-9 is colocalized in scattered neutrophils within diseased glomeruli in APSGN. MMP-9 gelatinolytic activity in five normal glomeruli was weakly detected. Consistent with the levels of immunostaining, MMP-9 glomerular activity was dra- matically increased in nephritic glomeruli with IgA nephritis, lupus nephritis and DN. The gelatinolytic activity of MMP-2 was occasionally detectable in nephritic glomeruli. Conclusion. These results strongly suggest that MMP-9 plays an important role in abnormal mesangial proliferative changes in human GN.
- 1 September 1996
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 27 (3) , 174-178
Rhabdoid tumor of the kidney: A report of two cases with respective tumor markers and a specific chromosomal abnormality, del(11p13)
- 1 September 1996
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 27 (3) , 174-178
Rhabdoid tumor of the kidney: A report of two cases with respective tumor markers and a specific chromosomal abnormality, del(11p13)
- 17 July 1996
- Published by Wiley in International Journal of Cancer
- Vol. 67 (2) , 218-223
Establishment and characterization of two cultured cell lines derived from malignant rhabdoid tumors of the kidney
Malignant rhabdoid tumor of the kidney (RTK) is a rare renal sarcoma of childhood. Its histogenesis is unclear, and it is highly resistant to multimodality therapy. To elucidate the origin and the oncogenetic potential of RTK, we investigated the characteristics of 2 newly established RTK cell lines, SWT-1 and SWT-2. Both cell lines were verified to be RTK, since they did not exhibit contact inhibition and exhibited intermediate filaments, a specific marker for RTK. These cells possess the characteristics of mesenchymal cells based on their positive reactions with anti-vimentin and anti-laminin antibodies and their negative reactions with anti-keratin and anti-desmin antibodies. The karyotype of SWT-1 was 46,XX and that of SWT-2 was 46,XX,del(11)(pter-p13::p12-qter). Since 11p13 is the location of the WT-1 tumor-suppressor gene, and del(11p13) is associated with the aniridia-Wilms'-tumor syndrome, these findings link RTK with Wilms' tumor. While SWT-1 was negative for the tumor markers examined, SWT-2 released tissue polypeptide antigen into the culture supernatant. No rearrangement or amplification of the myc and ras oncogenes or of the p53 tumor-suppressor gene were detected. Wild-type RB protein and cyclin A were expressed in both cells. Our data suggest that these 2 cell lines may be useful in identifying the oncogenetic pattern of RTK.
- 17 July 1996
- Published by Wiley in International Journal of Cancer
- Vol. 67 (2) , 218-223
Establishment and characterization of two cultured cell lines derived from malignant rhabdoid tumors of the kidney
Malignant rhabdoid tumor of the kidney (RTK) is a rare renal sarcoma of childhood. Its histogenesis is unclear, and it is highly resistant to multimodality therapy. To elucidate the origin and the oncogenetic potential of RTK, we investigated the characteristics of 2 newly established RTK cell lines, SWT-1 and SWT-2. Both cell lines were verified to be RTK, since they did not exhibit contact inhibition and exhibited intermediate filaments, a specific marker for RTK. These cells possess the characteristics of mesenchymal cells based on their positive reactions with anti-vimentin and anti-laminin antibodies and their negative reactions with anti-keratin and anti-desmin antibodies. The karyotype of SWT-1 was 46,XX and that of SWT-2 was 46,XX,del(11)(pter-p13::p12-qter). Since 11p13 is the location of the WT-1 tumor-suppressor gene, and del(11p13) is associated with the aniridia-Wilms'-tumor syndrome, these findings link RTK with Wilms' tumor. While SWT-1 was negative for the tumor markers examined, SWT-2 released tissue polypeptide antigen into the culture supernatant. No rearrangement or amplification of the myc and ras oncogenes or of the p53 tumor-suppressor gene were detected. Wild-type RB protein and cyclin A were expressed in both cells. Our data suggest that these 2 cell lines may be useful in identifying the oncogenetic pattern of RTK.